Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Distal Symmetric Polyneuropathy in 2020

Distal Symmetric Polyneuropathy in 2020 This JAMA Insights Clinical Update reviews the diagnosis and management of distal symmetric neuropathy, including control of risk factors (eg, high glucose in type 1 diabetes, weight loss) and use of nonpharmacologic and pharmacologic therapies (eg, SNRIs, tricyclic antidepressants, gabapentinoids). http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Distal Symmetric Polyneuropathy in 2020

JAMA , Volume 324 (1) – Jul 7, 2020

Loading next page...
 
/lp/american-medical-association/distal-symmetric-polyneuropathy-in-2020-5pC1mR00oV

References (10)

Publisher
American Medical Association
Copyright
Copyright 2020 American Medical Association. All Rights Reserved.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2020.0700
Publisher site
See Article on Publisher Site

Abstract

This JAMA Insights Clinical Update reviews the diagnosis and management of distal symmetric neuropathy, including control of risk factors (eg, high glucose in type 1 diabetes, weight loss) and use of nonpharmacologic and pharmacologic therapies (eg, SNRIs, tricyclic antidepressants, gabapentinoids).

Journal

JAMAAmerican Medical Association

Published: Jul 7, 2020

There are no references for this article.